Innovative Neuromodulation Neuronoff is a clinical-stage medical device company focused on neuromodulation therapies for chronic pain, presenting a compelling solution for pain management markets seeking non-opioid, minimally invasive options.

Injectrode Platform The Injectrode injectable electrode platform enables peripheral nerve stimulation via a standard clinical needle, offering a less invasive alternative to traditional implants that could accelerate adoption by surgeons and raise interest from specialty clinics.

IPG Compatibility Recent demonstrations of an IPG-compatible Injectrode system show scalable, remotely controllable stimulation across multiple neural targets, suggesting opportunities with ICD- and IPG-integrated care pathways and device integrators.

Strategic Funding Trajectory Past NIH grants and current funding rounds, including a recent $4.5M raise, indicate ongoing investor confidence and available capital to support clinical trials, partnerships, and speed-to-market initiatives.

Growth Signals Revenue is in the low-to-mid single digits with a total funding stack of about $12M, implying a market-entry stage with potential partnerships, distribution deals, and collaborations with larger medical device players to scale manufacturing and deployment.